Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Bull-like who wrote (669)	3/30/1999 6:18:00 PM
From: Captain Jack	Read Replies (2) \| Respond to of 942

Bull-like--- 60s several cycles ago.. so it has moved flat for several cycles?? I think the analysts are correct in where it should go (80 range) but 57 looks more probable than 77 at this point,,, actually has for some time.. each time it closes on 70 it is back in themid 60s. Nothing ranges forever and it can only go one of two ways. All indicators say it should have already moved up--- the recent stall by the FDA would have had the same impact no matter where it was. Now we see competition coming on Rez but going head to head with Prozak so PR wise it is a wash. The fundamentals should push it higher,,, but it runs lower. The possibility of funds dumping to clear their holding for the qtr is a possibility but would seem to have less an impact. If that is the case they will return beginning next week... if not the 50 range (56 - 59) is very possible IMO. The AGPH pipeline ( and do not forget the IMNR relationship) will provide opportunities but they will need publicized and R&D funding.. Needless to say I hope YOU are correct...